Relay Therapeutics, Inc.
RLAY
$3.18
-$0.08-2.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 781.32M | 839.61M | 688.42M | 749.61M | 750.09M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.35M | 18.73M | 10.12M | 13.19M | 16.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.53M | 6.80M | 5.73M | 7.30M | 3.32M |
| Total Current Assets | 809.20M | 865.13M | 704.27M | 770.10M | 770.10M |
|
|
|||||
| Total Current Assets | 809.20M | 865.13M | 704.27M | 770.10M | 770.10M |
| Net Property, Plant & Equipment | 57.67M | 60.57M | 63.27M | 66.33M | 68.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.30M | 2.30M | 2.30M | 2.30M | 2.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.12M | 2.12M | 2.71M | 2.71M | 2.71M |
| Total Assets | 871.30M | 930.12M | 772.55M | 841.44M | 843.98M |
|
|
|||||
| Total Accounts Payable | 14.10M | 6.87M | 11.17M | 7.97M | 9.21M |
| Total Accrued Expenses | 21.24M | 33.22M | 27.77M | 22.36M | 14.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.73M | 5.53M | 5.34M | 5.15M | 4.96M |
| Total Finance Division Other Current Liabilities | 9.67M | 1.36M | 768.00K | 1.66M | 1.20M |
| Total Other Current Liabilities | 9.67M | 1.36M | 768.00K | 1.66M | 1.20M |
| Total Current Liabilities | 50.73M | 46.97M | 45.04M | 37.14M | 30.27M |
|
|
|||||
| Total Current Liabilities | 50.73M | 46.97M | 45.04M | 37.14M | 30.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.78M | 44.29M | 45.76M | 47.16M | 48.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 11.37M | 13.21M |
| Total Liabilities | 93.50M | 91.25M | 90.81M | 95.68M | 91.98M |
|
|
|||||
| Common Stock & APIC | 2.52B | 2.50B | 2.26B | 2.23B | 2.15B |
| Retained Earnings | -1.74B | -1.66B | -1.57B | -1.48B | -1.40B |
| Treasury Stock & Other | -991.00K | 2.51M | -1.34M | -1.16M | -196.00K |
| Total Common Equity | 777.79M | 838.86M | 681.74M | 745.76M | 752.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 777.79M | 838.86M | 681.74M | 745.76M | 752.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 777.79M | 838.86M | 681.74M | 745.76M | 752.00M |
|
|
|||||